CHAVEZ TAPIA, NORBERTO CARLOS
INVESTIGACIÓN MÉDICA · Nivel 2
Meta-analysis
Liver
Cirrhosis
Desde 2011 es Chief en Medica Sur SA
Gastroenterologist and hepatologist at Medica Sur Clinic & Foundation
Gastroenterologist and hepatologist at Medica Sur Clinic & Foundation
| Nombre | NORBERTO CARLOS CHAVEZ TAPIA |
|---|---|
| Área | MEDICINA Y CIENCIAS DE LA SALUD |
| Campo | INVESTIGACIÓN MÉDICA |
| Disciplina | GASTROENTEROLOGÍA, FISIOLOGÍA DIGESTIVA |
| Especialidad | GASTROENTEROLOGIA |
| CVU | 122495 |
| Institución | |
|---|---|
| Dependencia | SIN INFORMACIÓN |
| Entidad | CIUDAD DE MEXICO |
| Nivel | 2 |
| Vigencia | Inicio: 01/01/2022 |
| Fin: 31/12/2026 |
Publicaciones ORCID
- 2026
- Current management of MASLD in type 2 diabetes Hormones
- 2025
- The pathophysiological link between type 1 diabetes and MASLD: insights into insulin resistance and liver dysfunction Journal of Endocrinological Investigation
- Metabolic-Dysfunction-Associated Steatotic Liver Disease: Molecular Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies International Journal of Molecular Sciences
- 2024
- ¿Qué se necesita para ser un investigador clínico? Medicina y Cultura
- Resmetirom, the long-awaited first treatment for metabolic dysfunction-associated steatohepatitis and liver fibrosis? Med
- Predictors for liver fibrosis in non-alcoholic patients with psoriatic diseases: A multicenter cross sectional-study PLOS ONE
- The Relationship between Pathogenesis and Possible Treatments for the MASLD-Cirrhosis Spectrum International Journal of Molecular Sciences
- 2023
- Prebiotics and Probiotics: Therapeutic Tools for Nonalcoholic Fatty Liver Disease International Journal of Molecular Sciences
- Understanding the Relationship between Nonalcoholic Fatty Liver Disease and Thyroid Disease International Journal of Molecular Sciences
- 2022
- COVID-19: Current Status in Gastrointestinal, Hepatic, and Pancreatic Diseases—A Concise Review Tropical Medicine and Infectious Disease
